DDr. Manfred Reichl (Chairman)

Manfred Reichl was Senior Partner at Roland Berger Strategy Consultants and Managing Director of the offices in Austria and Central and Eastern Europe. He studied law and civil engineering in Austria and has more than 20 years of extensive experience in international strategic consulting. Nowadays, he is a successful entrepreneur, investor and business angel. He was appointed Business Angel of the Year 2009.


Mag. Rainer C. Burian

Rainer Burian was founder and 25 years CEO of PAA Laboratories, a leading supplier of cell culture products to the biopharmaceutical industry. He developed the company from a small local lab to a global corporation with subsidiaries on three continents. Several company prizes were awarded to PAA under his leadership. In 2011, he sold the company to a multinational pharmaceutical corporation and became a successful investor and entrepreneur with extensive experience in the pharmaceutical and biotech industry. Rainer holds a Master in Business Administration (Mag.) from Vienna University of Economics and Business.


Josef Penninger, MD

Josef Penninger is the founding scientific director of IMBA and oversees all research activities at the institute. He studied Medicine and Arts at the University Innsbruck and worked as post-doctoral fellow since 1990 at the Ontario Cancer Institute. He is a Professor of Genetics at the University of Vienna, an Adjunct Full Professor of Immunology and Medical Biophysics at the University of Toronto, and holds a Honorary Professorship from the Chinese Academy of Medical Sciences. Josef worked for 13 years with Amgen Inc., the Ontario Cancer Institute, and the University of Toronto in Canada and is the founder of APEIRON Biologics.


Erwin Rasinger, MD

Erwin Rasinger is an Austrian physician and politician. He studied Medicine and Business Administration in Vienna and became referee for ecology of the Medical Association of Austria in 1981. In 1987, he joined the Municipal Council of Vienna as deputy and the National Assembly where he is deputy for healthcare since 1994.


Dr. Helmut Schuehsler

Dr. Helmut M. Schuehsler serves as Chairman and Managing Partner within TVM Capital Group and Chief Executive Officer of TVM Capital Healthcare Partners Ltd., Dubai, UAE. He is member of the board at several pharmaceutical companys, for more than 10 years, he served on the board of Max-Planck Innovation GmbH. Since joining TVM Capital in 1990, Dr. Schuehsler has been the deal maker on more than 30 direct investments in life science companies.